MedTrace Logo

Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants

NCT05768295 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-03-19

No results posted yet for this study

Summary

This Post-Market Clinical Follow-Up study aims to document the success and survival of the Axiom® BL X3 Implants up to 3 years after loading.

Conditions

  • Surgical Operation
  • Edentulous Jaw
  • Edentulous Mouth
  • Implant

Interventions

DEVICE

Axiom BL X3

collecting data on the use of Axiom BL X3 and patient satisfaction

Sponsors & Collaborators

  • Anthogyr

    lead INDUSTRY

Principal Investigators

  • Patrice Margossian, Dr · Cabinet Dr Margossian

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-05
Primary Completion
2025-08-20
Completion
2027-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05768295 on ClinicalTrials.gov